Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1993-08-26
1997-11-25
Wax, Robert A.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352402, 4352523, 43525411, 4353201, 4351723, 536 235, 536 2431, C12N 1512, C12N 1563, C12N 510, C12N 100
Patent
active
056911793
ABSTRACT:
A Bcl-2 associated protein (Bax) and uses thereof.
REFERENCES:
Silverman, G.A., et al., "Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene," Proc. Natl. Acad. Sci. USA, (1990) 87, 9913-9917.
Young, R.L., et al., "A Negative Regulatory Element in the bcl-2 5'-Untranslated Region Inhibits Expression from an Upstream Promoter," Mol. & Cell Biol., (1993) 13:6, 3686-3697.
Nunez, G., et al., "Deregulated Bcl-2 Gene Expression Selectively Prolongs Survival of Growth Factor-Deprived Hemopoietic Cell Lines," J. Immun., (1990) 144:9, 3602-3610.
Sentman, C.L., "blc-2 Inhibits Multiple Forms of Apoptosis but Not Negative Selection in Thymocytes," Cell, (1991) 67, 879-888.
Nunez, G., et al., "Bcl-2 maintains B cell memory," Nature, (1991) 353, 71-73.
McDonnell, T.J., et al., "Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)," Nature, (1991) 349, 254-256.
McDonnell, T.J., et al., "Deregulated Bcl-2-Immunoglobulin Transgene Expands a Resting but Responsive Immunoglobulin M and D-Expressing B-Cell Population," Mol. & Cell Biol., (1990) 10:5, 1901-1907.
McDonnell, T.J., et al., "bcl-2-Immunoglobulin Transgenic Mice Demonstrate Extended B Cell Survival and Follicular Lymphoproliferation," Cell, (1989) 57, 79-88.
Zutter, M., et al., "Immunolocalization of the Bcl-2 Protein Within Hematopoietic Neoplasms," Blood, (1991) 78:4, 1062-1068.
Hockenbery, D.M., "BCL2 Protein is topographically restricted in tissues characterized by apoptotic cell death," Proc. Natl. Acad. Sci. USA, (1991) 88, 6961-6965.
Hockenbery, D.M., "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death," Nature, (1990) 348, 334-336.
Korsmeyer, S.J., "Bcl-2 Initiates a New Category of Oncogenes: Regulators of Cell Death," Blood, (1992) 80:4, 879-886.
Nakayama, K., "Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice," Science, (1993) 261, 1584-1588.
Korsmeyer, S.J., "Bcl-2: An Antidote to Programmed Cell Death," Cancer Surveys, (1992) 15, 105-118.
Korsmeyer, S.J., "Bcl-2: a repressor of lymphocyte death," Immunology Today, (1992) 13, 285-288.
McKearn et al. (1985) Proc. Nat. Acad. Sci., U.S.A., 82: 7414-7418.
Lipford et al. (1987) Blood 70: 1816-1823.
Cleary et al. (1986) Cell 47: 19-28.
Kozopas et al. (1993) Proc. Nat. Acad. Sci., U.S.A. 90: 3516-3520.
Yin et al. (1994), "BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax," Nature 369:321-323.
Yin et al. (1993), "BCL-2 functions by counteracting its dimerization partner, Bax, a death accelerator protein," Blood 82(10):441A, abstract No. 1749.
Bugaisky G. E.
Washington University
Wax Robert A.
LandOfFree
Cell death regulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell death regulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell death regulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2106021